Quick Overview
- ARK Invest divested 3,578 shares of Meta valued at approximately $2.1 million from three separate funds
- The investment firm offloaded 95,090 Roku shares representing roughly $9.1 million in value across various ETFs
- ARK acquired 84,939 Tempus AI shares totaling about $4.1 million during Wednesday’s trading session
- Tempus AI has climbed to become the third-largest position in ARK Innovation ETF, comprising approximately 5% of portfolio weight
- Meta faced legal setbacks in a social media addiction lawsuit and announced workforce reductions affecting hundreds
Cathie Wood’s investment management firm ARK Invest executed strategic portfolio adjustments on Wednesday, March 25, reducing exposure to Meta and Roku while channeling capital toward healthcare artificial intelligence specialist Tempus AI.
The investment firm liquidated 3,578 shares of Meta distributed across three fund holdings. Calculated using Wednesday’s closing market price, the transaction totaled approximately $2.1 million. Following this divestment, the ARK Innovation ETF maintains a position of roughly 105,000 Meta shares valued near $63 million — representing about 1% of total fund assets.
Wednesday proved eventful for Meta on multiple fronts. A jury delivered a verdict finding both Meta and Google’s YouTube platform liable for negligence in operating services that caused harm to minors and adolescents in a precedent-setting social media addiction lawsuit. Both technology giants announced intentions to challenge the ruling through appeals.
Meta simultaneously introduced a revised executive compensation structure designed to incentivize achieving a 500% stock appreciation and reaching a $9 trillion market capitalization by 2031. The social media conglomerate acknowledged to Barron’s that it was implementing workforce reductions affecting several hundred positions spanning sales operations, talent acquisition, and virtual reality business units. Remarkably, despite these developments, Meta’s stock price advanced a modest 0.3% by market close.
ARK simultaneously divested 95,090 Roku shares spread across its ARKK, ARKW, and ARKF fund portfolios, representing approximately $9.1 million in aggregate value. This transaction continues a selling pattern, following substantial Roku share sales executed one day earlier on March 24.
Additional Wednesday divestments encompassed 30,174 Teradyne shares valued at roughly $9.7 million, alongside 205,019 Bullish shares distributed across three ETFs totaling about $7.7 million. ARK has maintained consistent Bullish share liquidation activity throughout the preceding week.
Further portfolio reductions included disposing of 62,393 Kratos Defense shares and 27,647 Natera shares, generating proceeds of $4.8 million and $5.4 million respectively.
ARK’s Significant Tempus AI Investment
Regarding acquisitions, ARK’s primary capital deployment targeted Tempus AI. The management firm purchased 84,939 shares distributed between its ARKK and ARKG ETF vehicles, investing approximately $4.1 million.
Tempus AI experienced a 4.2% price decline on Wednesday and has decreased 21% year-to-date in 2026. ARK’s acquisition timing suggests a strategic opportunity purchase during a price correction.
ARK Innovation ETF currently maintains approximately 6.3 million Tempus AI shares with a market value exceeding $294 million. This position has elevated to the fund’s third-largest holding, trailing only Tesla and Crispr Therapeutics, representing roughly 5% of aggregate portfolio allocation.
Strategic Portfolio Rotation Pattern
ARK’s Wednesday transaction activity reflects a systematic reallocation strategy. The firm has methodically decreased holdings in Roku, Teradyne, and Bullish across multiple consecutive trading sessions.
Concurrently, the investment manager has been systematically expanding its Tempus AI exposure. Tempus AI operates as a healthcare technology enterprise leveraging artificial intelligence capabilities to enhance medical data analytics and oncology treatment.
Supplementary acquisitions during the trading day encompassed shares of Archer Aviation, Beam Therapeutics, and additional portfolio companies.
The ARK Innovation ETF concluded Wednesday’s session with a 1.3% gain.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
